• 国家药监局综合司 国家卫生健康委办公厅
  • 国家药监局综合司 国家卫生健康委办公厅

Exploring Professor Xiong Yan

Corresponding author: ZHANGT Tao, hello_zhangtao@aliyun.com
DOI: 10.12201/bmr.202509.00053
Statement: This article is a preprint and has not been peer-reviewed. It reports new research that has yet to be evaluated and so should not be used to guide clinical practice.
  •  

    Abstract: Non-alcoholic fatty liver disease (NAFLD) has a complex pathogenesis. In traditional Chinese medicine (TCM), its occurrence is closely associated with dietary habits, emotional factors, and constitutional predisposition. Based on the “Xiao Fa” (dispersion method) theory, this article systematically summarizes Professor Xiong Yan’s clinical experience in treating NAFLD, highlighting innovations in pathological mechanism interpretation and stratified treatment.Professor Xiong identifies three key pathological mechanisms: dietary irregularities leading to spleen-stomach impairment, emotional disorders causing liver stagnation overacting on the spleen, and congenital deficiency resulting in phlegm and stasis binding together. These factors interact, ultimately leading to liver-spleen dysfunction and phlegm-stasis obstruction.Therapeutically, centering on “Xiao Fa,” a stratified treatment approach is adopted: promoting digestion and removing stagnation, awakening the spleen and resolving turbidity to strengthen the middle energizer; soothing the liver and relieving depression, eliminating stagnation and harmonizing collaterals to regulate qi movement; resolving phlegm and dissipating stasis, supporting healthy qi and unblocking collaterals to eliminate pathogens and consolidate constitution. Professor Xiong also developed the empirical formula “Zhi Kang Yin” to simultaneously address the liver and spleen, and treat both phlegm and stasis, reflecting the uniqueness and practicality of his clinical approach. This provides a new effective formula and clinical pathway for TCM treatment of NAFLD.

    Key words: Non-alcoholic fatty liver disease,Therapy of Dispelling,Zhi Kang Yin,Experience

    Submit time: 24 September 2025

    Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
  • 图表

  • 王馨雨, ZHANG Shujuan. Research progress of GLP-2 in non-alcoholic fatty liver disease. 2025. doi: 10.12201/bmr.202502.00018

    Chen Zhiyun. Effects of common environmental pollutants on non-alcoholic fatty liver disease. 2025. doi: 10.12201/bmr.202506.00049

    NIU Xiao Shan. Advances in pharmacological studies of NF-κB involved in the regulation of nonalcoholic fatty liver disease. 2024. doi: 10.12201/bmr.202410.00006

    Li Xue, Fei Yue, Xu Xiahong. Exploring the relationship between serum ferritin and metabolic-associated fatty liver disease in adolescents based on NHANES database. 2025. doi: 10.12201/bmr.202503.00012

    JIA Chen, GONG Yan, HAN Yijing, JIANG Jianan, LIU Weizheng, ZHANG Daxu, LU Wenping. Correlation between psychological stress and metabolic-associated fatty liver disease. 2022. doi: 10.12201/bmr.202204.00003

    . 2025. doi: 10.12201/bmr.202507.00044

    Xiaozhihong. . 2025. doi: 10.12201/bmr.202509.00057

    Song Si-Meng, Wang Shi-Liang, Wu da-hua, XIE Le. Professor Zhou Shens experience in treating delayed motor disorder based on the theory of. 2025. doi: 10.12201/bmr.202509.00038

    刘永淳, Luo Liangtao, Gao Zhongying. Professor Gao Zhongyings experience in treating chronic atrophic gastritis from the theory of. 2024. doi: 10.12201/bmr.202410.00062

    Tian Lin. Professor Tian Lins Experience Sharing and Case Studies in the Treatment of Lung Adenocarcinoma. 2025. doi: 10.12201/bmr.202506.00019

  • ID Submit time Number Download
    1 2025-09-12

    10.12201/bmr.202509.00053V1

    Download
  • Public  Anonymous  To author only

Get Citation

XIONG Yan, ZHANGT Tao. Exploring Professor Xiong Yan. 2025. biomedRxiv.202509.00053

Article Metrics

  • Read: 316
  • Download: 0
  • Comment: 0

Email This Article

User name:
Email:*请输入正确邮箱
Code:*验证码错误